Correlation Between Ardelyx and Iovance Biotherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ardelyx and Iovance Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and Iovance Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ardelyx and Iovance Biotherapeutics, you can compare the effects of market volatilities on Ardelyx and Iovance Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of Iovance Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and Iovance Biotherapeutics.

Diversification Opportunities for Ardelyx and Iovance Biotherapeutics

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Ardelyx and Iovance is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and Iovance Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iovance Biotherapeutics and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with Iovance Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iovance Biotherapeutics has no effect on the direction of Ardelyx i.e., Ardelyx and Iovance Biotherapeutics go up and down completely randomly.

Pair Corralation between Ardelyx and Iovance Biotherapeutics

Given the investment horizon of 90 days Ardelyx is expected to generate 0.88 times more return on investment than Iovance Biotherapeutics. However, Ardelyx is 1.14 times less risky than Iovance Biotherapeutics. It trades about 0.04 of its potential returns per unit of risk. Iovance Biotherapeutics is currently generating about 0.03 per unit of risk. If you would invest  399.00  in Ardelyx on September 2, 2024 and sell it today you would earn a total of  168.00  from holding Ardelyx or generate 42.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Ardelyx  vs.  Iovance Biotherapeutics

 Performance 
       Timeline  
Ardelyx 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Ardelyx are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Ardelyx may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Iovance Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Ardelyx and Iovance Biotherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ardelyx and Iovance Biotherapeutics

The main advantage of trading using opposite Ardelyx and Iovance Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, Iovance Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iovance Biotherapeutics will offset losses from the drop in Iovance Biotherapeutics' long position.
The idea behind Ardelyx and Iovance Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum